Inst Diagnosti Working Capital to Net Assets Ratio
Inst Diagnosti working capital to net assets ratio. Inst Diagnosti (INDISA) has a Working Capital to Net Assets ratio of 5.6% as of March 2026. Working capital of CL$12.32 Billion (current assets of CL$108.43 Billion minus current liabilities of CL$96.11 Billion) is measured against net assets of CL$221.01 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check INDISA tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Inst Diagnosti (2014–2025)
Working capital to net assets ratio of Inst Diagnosti from 2014 to 2025. This chart shows how Inst Diagnosti's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 5.6%, reflecting working capital of CL$12.32 Billion against net assets of CL$221.01 Billion CLP. See INDISA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Inst Diagnosti Working Capital to Net Assets Ratio by Year (2014–2025)
Inst Diagnosti working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Inst Diagnosti from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see INDISA total asset value.
| Year | WC/NA Ratio | Working Capital (CLP) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 8.2% | CL$16.96 Billion | CL$207.27 Billion | CL$111.94 Billion | CL$94.97 Billion | ▼ -6.0 pp |
| 2024 | 14.2% | CL$15.49 Billion | CL$109.16 Billion | CL$98.84 Billion | CL$83.35 Billion | ▲ +3.7 pp |
| 2023 | 10.5% | CL$10.89 Billion | CL$104.02 Billion | CL$99.63 Billion | CL$88.74 Billion | ▼ -0.2 pp |
| 2022 | 10.7% | CL$10.90 Billion | CL$101.70 Billion | CL$99.25 Billion | CL$88.36 Billion | ▲ +20.9 pp |
| 2021 | -10.2% | CL$-9.67 Billion | CL$95.17 Billion | CL$86.22 Billion | CL$95.89 Billion | ▼ -24.9 pp |
| 2020 | 14.7% | CL$12.49 Billion | CL$84.82 Billion | CL$71.36 Billion | CL$58.87 Billion | ▼ -12.4 pp |
| 2019 | 27.2% | CL$22.25 Billion | CL$81.92 Billion | CL$66.90 Billion | CL$44.66 Billion | ▼ -4.2 pp |
| 2018 | 31.4% | CL$23.89 Billion | CL$76.08 Billion | CL$65.28 Billion | CL$41.39 Billion | ▲ +1.1 pp |
| 2017 | 30.3% | CL$20.92 Billion | CL$69.00 Billion | CL$64.49 Billion | CL$43.57 Billion | ▼ -8.0 pp |
| 2016 | 38.3% | CL$24.14 Billion | CL$63.05 Billion | CL$65.10 Billion | CL$40.96 Billion | ▲ +12.1 pp |
| 2015 | 26.1% | CL$14.83 Billion | CL$56.73 Billion | CL$56.33 Billion | CL$41.50 Billion | ▲ +4.7 pp |
| 2014 | 21.5% | CL$10.76 Billion | CL$50.16 Billion | CL$42.02 Billion | CL$31.25 Billion | — |